statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	737
SG - Singapore	310
CN - Cina	205
IT - Italia	171
BR - Brasile	162
RU - Federazione Russa	142
VN - Vietnam	123
BD - Bangladesh	64
HK - Hong Kong	46
DE - Germania	39
CA - Canada	37
FR - Francia	34
GB - Regno Unito	32
IN - India	29
FI - Finlandia	28
ID - Indonesia	18
MX - Messico	18
AR - Argentina	17
PL - Polonia	17
TR - Turchia	16
EC - Ecuador	15
NL - Olanda	12
IQ - Iraq	10
AT - Austria	9
CO - Colombia	7
ES - Italia	7
PE - Perù	6
PK - Pakistan	6
SE - Svezia	6
VE - Venezuela	6
JP - Giappone	5
CH - Svizzera	4
IL - Israele	4
MY - Malesia	4
PY - Paraguay	4
UA - Ucraina	4
UZ - Uzbekistan	4
CL - Cile	3
JO - Giordania	3
KZ - Kazakistan	3
LT - Lituania	3
SI - Slovenia	3
BY - Bielorussia	2
CI - Costa d'Avorio	2
DO - Repubblica Dominicana	2
GR - Grecia	2
KE - Kenya	2
NI - Nicaragua	2
NO - Norvegia	2
TH - Thailandia	2
AE - Emirati Arabi Uniti	1
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
AU - Australia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BB - Barbados	1
BE - Belgio	1
CG - Congo	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
GE - Georgia	1
GT - Guatemala	1
IE - Irlanda	1
JM - Giamaica	1
LB - Libano	1
LV - Lettonia	1
MA - Marocco	1
NC - Nuova Caledonia	1
NP - Nepal	1
OM - Oman	1
PH - Filippine	1
PS - Palestinian Territory	1
RO - Romania	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
ZA - Sudafrica	1
Totale	2.422

Nome	#
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis	306
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study	260
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis	231
Sex-specific associations of myocardial perfusion imaging with outcomes in patients with suspected chronic coronary syndrome	217
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis	215
Tissue Characterization in Cardiac Amyloidosis	211
Positron emission tomography in cardiac amyloidosis: current evidence and future directions	200
PET and Cardiac Amyloidosis	196
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis	188
Automated Neural Architecture Search for Cardiac Amyloidosis Classification from [18F]-Florbetaben PET Images	184
Diagnosis and Prognostication With PET Imaging: The (Next) Future in Light Chain Amyloidosis	163
Diagnosis and Prognostication With PET Imaging: The (Next) Future in Light Chain Amyloidosis	38
Dogmas and heresies in coronary blood flow regulation	33
Totale	2.442

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2023/2024	24	0	0	4	4	0	3	2	1	0	0	0	10
2024/2025	445	8	14	28	4	20	18	53	73	31	16	71	109
2025/2026	1.973	135	262	197	290	185	137	140	101	167	122	133	104
Totale													2.442